INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.390
+0.040 (2.96%)
At close: May 12, 2026, 4:00 PM EDT
1.370
-0.020 (-1.44%)
After-hours: May 12, 2026, 7:54 PM EDT
INmune Bio Employees
INmune Bio had 21 employees as of December 31, 2025. The number of employees decreased by 1 or -4.55% compared to the previous year.
Employees
21
Change (1Y)
-1
Growth (1Y)
-4.55%
Revenue / Employee
n/a
Profits / Employee
-$1,981,000
Market Cap
36.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | -1 | -4.55% | 21 | 0 |
| Dec 31, 2024 | 22 | 5 | 29.41% | 13 | 9 |
| Dec 31, 2023 | 17 | 7 | 70.00% | 11 | 6 |
| Dec 31, 2022 | 10 | 0 | - | 10 | 0 |
| Dec 31, 2021 | 10 | 5 | 100.00% | 10 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Aligos Therapeutics | 82 |
| Evaxion | 46 |
| NextCure | 40 |
| Palatin Technologies | 29 |
| Daré Bioscience | 24 |
| Veru Inc. | 20 |
| RenovoRx | 17 |
INMB News
- 5 days ago - INmune Bio Earnings Call Transcript: Q1 2026 - Transcripts
- 5 days ago - INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update - GlobeNewsWire
- 7 days ago - INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases - GlobeNewsWire
- 12 days ago - INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th - GlobeNewsWire
- 26 days ago - INmune Bio announces new preclinical data for INB03 - TheFly
- 6 weeks ago - INmune Bio Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - INmune Bio Inc. Announces 2025 Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th. - GlobeNewsWire